Abstract:Micromolar concentrations of beta-amyloid (Abeta), a 40/42-amino-acid-long proteolytic fragment (Abeta(1-40/42)) of the amyloid precursor protein, was shown previously to play a crucial role in pathogenesis of Alzheimer's disease. We used the Xenopus oocyte expression system to investigate specific effects of micromolar concentrations of Abeta(1-42) on the neurotransmitter transporters for gamma-aminobutyric acid (GABA), GAT1, and for the excitatory amino acid glutamate, EAAC1, which are driven by the transmembrane Na+ gradient that is regulated by the Na+,K+-ATPase. Brief treatment with Abeta(1-42), up to 80 min, leads to a significant inhibition of ion translocation by the Na+, K+-ATPase (30-40%); also glutamate uptake is inhibited (20%) while GABA uptake is not affected. Since reduced glutamate uptake will result in elevated, neurotoxic concentrations of extracellular glutamate, we investigated the effects of Abeta(1-42) and the smaller fragments, Abeta(12-28) and Abeta(25-35), on EAAC1 in more detail. Prolonged incubation in 1 muM Abeta(1-42) leads to further, strong inhibition of glutamate uptake and EAAC1-mediated current (after 4 h inhibition amounts to more than 80%). Abeta(12-28) is less effective with 50% inhibition after 4 h of incubation at 20 muM. Abeta(1-42) and Abeta(12-28) affect EAAC1-mediated current to a similar extent as the rate of glutamate uptake. The effects on EAAC1-mediated current are irreversible if Abeta were applied for longer time periods. Peptides directly microinjected into the oocyte are ineffective suggesting that the observed effect were mediated by extracellular proteins. Abeta(25-35) hardly affects EAAC1-mediated current or glutamate uptake.The results demonstrate that Abeta specifically inhibits the Na+,K+ pump and EAAC1. The domain between amino acids 12 and 28 of Abeta seems to play a crucial role for inhibition of EAAC1. The inhibition of EAAC1 by neurotoxic, elevated extracellular glutamate levels may contribute to Alzheimer's pathogenesis. (C) 2004 IBRO. Published by Elsevier Ltd. All rights reserved.

H2O2 and PAF mediate Abeta1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761

P2X receptor overexpression induced by soluble oligomers of amyloid beta peptide potentiates synaptic failure and neuronal dyshomeostasis in cellular models of Alzheimer's disease

Heme-Aβ in SDS micellar environment: Active site environment and reactivity

Protective effect of EGb761 against Aβ1-42 -induced SHSY5Y cells injury and blood-brain barrier disruption via regulating Akt/Nrf2 signaling pathway

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease

Hydrogen Peroxide Promotes Aβ Production Through JNK-dependent Activation of Γ-Secretase

Dual Functions of Beta-Amyloid Oligomer and Fibril in Cu(Ii)-Induced H2o2 Production

Peoniflorin Attentuates Aβ(1–42)-mediated Neurotoxicity by Regulating Calcium Homeostasis and Ameliorating Oxidative Stress in Hippocampus of Rats

Aβ1-42 oligomers induced a short-term increase of glutamate release prior to its depletion as measured by amperometry on single varicosities.

Oligomerized Abeta25-35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield.

Amyloid Β Oligomers Suppress Excitatory Transmitter Release Via Presynaptic Depletion of Phosphatidylinositol-4,5-bisphosphate

Oligomerized Aβ25–35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield

Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology

The mechanism for heme to prevent Aβ 1–40 aggregation and its cytotoxicity

Hyperbaric Oxygen and Ginkgo Biloba Extract Inhibit Aβ25-35-induced Toxicity and Oxidative Stress in Vivo: a Potential Role in Alzheimer's Disease.

Ppar Delta Agonist Gw0742 Ameliorates A Beta(1-42)-Induced Hippocampal Neurotoxicity In Mice

Modulation of Na+,K+ Pumping and Neurotransmitter Uptake by $Beta;-Amyloid

Involvement of P38MAPK Activation by NMDA Receptors and Non-Nmda Receptors in Amyloid-Β Peptide-Induced Neuronal Loss in Rat Hippocampal CA1 and CA3 Subfields

Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling